# ARATANA THERAPEUTICS, INC.

ARATANA THERAPEUTICS, INC. is a company headquartered in Leawood, KS, United States.

## Company overview

- **Legal name:** ARATANA THERAPEUTICS, INC.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Leawood, KS, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001509190

## About

ARATANA THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001509190, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-13, it reported annual revenue of USD 35,412,000; net income of USD -14,722,000; total assets of USD 106,436,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $35.4M (USD 35,412,000)
- **Net income:** -$14.7M (USD -14,722,000)
- **Total assets:** $106.4M (USD 106,436,000)
- **Cash and equivalents:** $41.4M (USD 41,431,000)
- **Operating cash flow:** -$11.3M (USD -11,261,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $25.6M (USD 25,573,000)
- **Net income:** -$47.5M (USD -47,510,000)
- **Total assets:** $135.2M (USD 135,192,000)
- **Cash and equivalents:** $66.9M (USD 66,868,000)
- **Operating cash flow:** -$38.2M (USD -38,185,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $38.6M (USD 38,551,000)
- **Net income:** -$33.6M (USD -33,575,000)
- **Total assets:** $151.4M (USD 151,406,000)
- **Cash and equivalents:** $87.3M (USD 87,307,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $678,000 (USD 678,000)
- **Net income:** -$84.1M (USD -84,054,000)
- **Total assets:** $147.1M (USD 147,066,000)
- **Cash and equivalents:** $26.8M (USD 26,755,000)

## Recent SEC filings

- Form SC 13G — filed 2019-07-29
- Form 8-K — filed 2019-07-18 — period 2019-07-18 — 8-K
- Form 8-K — filed 2019-07-16 — period 2019-07-16 — 8-K
- Form 8-K — filed 2019-07-02 — period 2019-07-02 — 8-K
- Form 8-K — filed 2019-06-07 — period 2019-06-07 — 8-K
- Form 10-Q — filed 2019-05-09 — period 2019-03-31 — 10-Q
- Form 8-K — filed 2019-05-08 — period 2019-05-08 — 8-K
- Form 8-K — filed 2019-04-26 — period 2019-04-26 — 8-K
- Form DEF 14A — filed 2019-04-19 — period 2019-04-19 — DEF 14A
- Form 8-K — filed 2019-03-15 — period 2019-03-15 — 8-K
- Form 10-K — filed 2019-03-13 — period 2018-12-31 — 10-K
- Form 8-K — filed 2019-03-12 — period 2019-03-12 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/aratana-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology